secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2026-04-01T23:59:59+00:00
Accession:  0001477932-26-001940
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx shareholders approve share issuance to Lind Global and reverse stock split authorization
--------------------------------------------------------------------------------

- Proposal 1 (issuance >20% to Lind Global): 44.15M for, 14.10M against, 1.11M abstain, 21.15M broker non-votes approved.
- Proposal 2 (reverse split authorization): 62.84M for, 16.45M against, 1.22M abstain; board may choose ratio 1:5 to 1:20.
- Record date Feb 9, 2026: 135.57M shares outstanding; 80.51M shares present at special meeting on March 31, 2026.
- No other matters were presented for stockholder action at the special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793226001940/0001477932-26-001940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793226001940/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-001940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer